Analyze Diet
Journal of the American Veterinary Medical Association2001; 218(12); 1957-1960; doi: 10.2460/javma.2001.218.1957

Prevalence and clinical implications of anthelmintic resistance in cyathostomes of horses.

Abstract: To determine the prevalence and clinical implications of anthelmintic resistance in cyathostomes of horses. Methods: Prospective study. Methods: 80 horses on 10 farms in a 5-county region of northeast Georgia. Methods: On each farm, horses were stratified in descending order according to pretreatment fecal egg count (FEC), blocked into groups of 4, and then randomly assigned to 1 of 4 treatment groups: no treatment (controls), and treatment with pyrantel pamoate, fenbendazole, or ivermectin. Fecal samples were collected 24 hours prior to treatment and 2, 4, and 6 weeks after treatment for determination of FEC. Mean percentage of reduction in FEC was then calculated for each treatment group. For horses from each farm, the efficacy of each anthelmintic was categorized on the basis of mean percentage of reduction in FEC at 2 weeks after treatment (< 80% reduction = ineffective; 80 to 90% reduction = equivocal; and > 90% reduction = effective). Results: Pyrantel pamoate was effective at reducing FEC in horses from 7 farms, ineffective in horses from 2 farms, and equivocal in horses from 1 farm. Fenbendazole was ineffective at reducing FEC in horses from 9 farms and equivocal in horses from 1 farm. Ivermectin was effective at reducing FEC in horses from all 10 farms. Conclusions: Results suggest that cyathostome resistance to fenbendazole is highly prevalent, and resistance to pyrantel pamoate is high enough to warrant concern. Resistance to ivermectin was not detected. On the basis of these data, it appears that ivermectin continues to be fully effective in horses. However, too few farms were used in this study to determine the prevalence of cyathostome resistance to ivermectin. Therefore, the efficacy of ivermectin should continue to be monitored closely.
Publication Date: 2001-06-22 PubMed ID: 11417741DOI: 10.2460/javma.2001.218.1957Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Clinical Trial
  • Journal Article
  • Randomized Controlled Trial
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates how widespread, and what the implications are, of anthelmintic resistance in a type of parasitic worm (cyathostomes) that affect horses. The study found that some common treatments were less effective, but no resistance was detected to one drug, called ivermectin.

About the Study

  • The study was set out to understand the prevalence and clinical implications of drug resistance in cyathostomes, a specific type of parasitic worm that burdens horses, to common anthelmintic treatments.
  • In this prospective research, 80 horses from 10 different farms in northeast Georgia were studied. The researchers used three common anthelmintic drugs: pyrantel pamoate, fenbendazole, and ivermectin, alongside a control group that received no treatment.
  • The horses were classified in a descending order based on their pre-treatment fecal egg count (FEC), divided into groups of 4, and then randomly allocated to one of the four treatment groups.
  • To determine the effectiveness of each drug, fecal samples were taken 24 hours before treatment and then at 2, 4, and 6 weeks after treatment to calculate the FEC. The mean percentage reduction in FEC was then determined for each treatment group.

Findings of the Study

  • The findings of the study indicated that resistance to fenbendazole was highly prevalent as it was ineffective at reducing FEC in horses from 9 out of 10 farms. Similarly, resistance to pyrantel pamoate was evident in horses from 2 farms, raising concerns about its efficacy.
  • On the other hand, ivermectin was found to be effective in reducing FEC in horses from all 10 farms. This suggests there was no detected resistance to ivermectin among the studied population.
  • However, the researchers caution that there was a small sample size in this study and the complete prevalence of cyathostome resistance to ivermectin couldn’t be accurately determined. Therefore, the efficacy of ivermectin should continue to be monitored closely.

Implications and Conclusions

  • Resistance to anthelmintic treatment in cyathostomes of horses appears to be an emerging concern. The effectiveness of fenbendazole and pyrantel pamoate was found to be compromised due to resistance.
  • However, ivermectin remains fully effective in treating horses affected by these parasites. The study emphasises a need for continuous monitoring to detect any potential emergence of ivermectin resistance in the future.
  • In light of these findings, a periodic review of anthelmintic treatment strategies might be necessary to ensure effective controlling of the parasites in horses.

Cite This Article

APA
Tarigo-Martinie JL, Wyatt AR, Kaplan RM. (2001). Prevalence and clinical implications of anthelmintic resistance in cyathostomes of horses. J Am Vet Med Assoc, 218(12), 1957-1960. https://doi.org/10.2460/javma.2001.218.1957

Publication

ISSN: 0003-1488
NlmUniqueID: 7503067
Country: United States
Language: English
Volume: 218
Issue: 12
Pages: 1957-1960

Researcher Affiliations

Tarigo-Martinie, J L
  • Department of Medical Microbiology and Parasitology, College of Veterinary Medicine, University of Georgia, Athens 30602, USA.
Wyatt, A R
    Kaplan, R M

      MeSH Terms

      • Animals
      • Anthelmintics / pharmacology
      • Anthelmintics / therapeutic use
      • Drug Resistance
      • Feces / parasitology
      • Female
      • Fenbendazole / pharmacology
      • Fenbendazole / therapeutic use
      • Georgia / epidemiology
      • Horses
      • Intestinal Diseases, Parasitic / drug therapy
      • Ivermectin / pharmacology
      • Ivermectin / therapeutic use
      • Male
      • Parasite Egg Count / veterinary
      • Prevalence
      • Prospective Studies
      • Pyrantel Pamoate / pharmacology
      • Pyrantel Pamoate / therapeutic use
      • Strongyle Infections, Equine / drug therapy
      • Strongyloidea / drug effects
      • Treatment Outcome

      Citations

      This article has been cited 9 times.
      1. Macdonald SL, Abbas G, Ghafar A, Gauci CG, Bauquier J, El-Hage C, Tennent-Brown B, Wilkes EJA, Beasley A, Jacobson C, Cudmore L, Carrigan P, Hurley J, Beveridge I, Hughes KJ, Nielsen MK, Jabbar A. Egg reappearance periods of anthelmintics against equine cyathostomins: The state of play revisited. Int J Parasitol Drugs Drug Resist 2023 Apr;21:28-39.
        doi: 10.1016/j.ijpddr.2022.12.002pubmed: 36543048google scholar: lookup
      2. Nielsen MK. Anthelmintic resistance in equine nematodes: Current status and emerging trends. Int J Parasitol Drugs Drug Resist 2022 Dec;20:76-88.
        doi: 10.1016/j.ijpddr.2022.10.005pubmed: 36342004google scholar: lookup
      3. Dauparaitė E, Kupčinskas T, Varady M, Petkevičius S. Anthelmintic resistance of horse strongyle nematodes to fenbendazole in Lithuania. Acta Vet Scand 2022 Sep 15;64(1):26.
        doi: 10.1186/s13028-022-00645-ypubmed: 36109767google scholar: lookup
      4. Nápravníková J, Várady M, Vadlejch J. Total Failure of Fenbendazole to Control Strongylid Infections in Czech Horse Operations. Front Vet Sci 2022;9:833204.
        doi: 10.3389/fvets.2022.833204pubmed: 35265696google scholar: lookup
      5. Zak A, Siwinska N, Slowikowska M, Borowicz H, Kubiak K, Hildebrand J, Popiolek M, Niedzwiedz A. Searching for ivermectin resistance in a Strongylidae population of horses stabled in Poland. BMC Vet Res 2017 Jul 3;13(1):210.
        doi: 10.1186/s12917-017-1133-1pubmed: 28673347google scholar: lookup
      6. Matthews JB. Anthelmintic resistance in equine nematodes. Int J Parasitol Drugs Drug Resist 2014 Dec;4(3):310-5.
        doi: 10.1016/j.ijpddr.2014.10.003pubmed: 25516842google scholar: lookup
      7. Reinemeyer CR. Diagnosis and control of anthelmintic-resistant Parascaris equorum. Parasit Vectors 2009 Sep 25;2 Suppl 2(Suppl 2):S8.
        doi: 10.1186/1756-3305-2-S2-S8pubmed: 19778469google scholar: lookup
      8. Lind EO, Kuzmina T, Uggla A, Waller PJ, Höglund J. A field study on the effect of some anthelmintics on cyathostomins of horses in sweden. Vet Res Commun 2007 Jan;31(1):53-65.
        doi: 10.1007/s11259-006-3402-5pubmed: 17186406google scholar: lookup
      9. Christie JL, Hewson CJ, Riley CB, Mcniven MA, Dohoo IR, Bate LA. Demographics, management, and welfare of nonracing horses in Prince Edward Island. Can Vet J 2004 Dec;45(12):1004-11.
        pubmed: 15646847